L-arginine-glycine amidinotransferase, betaine-homocysteine s-methyltransferase, and neuropolypeptide h3 are diminished in renal clear cell carcinoma of humans

Saudi Medical Journal

Volumn 32, Issue 5, 2011, Pages 467-473

  Peng, Jian Ping ^a   Zhang, Jie ^a,b   Huang, Hsuan Wei ^a   Wang, Feng Hua ^a   Du, Xian Jin ^a   Luo, Peng Cheng ^a  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE HOMOCYSTEINE METHYLTRANSFERASE; GLYCINE AMIDINOTRANSFERASE; KETOHEXOKINASE; MESSENGER RNA; NEUROPOLYPEPTIDE H3; POLYPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

AGED; AMIDINOTRANSFERASES; BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79957607236     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Banks RE, Craven RA, Harnden P, Madaan S, Joyce A, Selby PJ. Key clinical issues in renal cancer: a challenge for proteomics. World J Urol 2007; 25: 537-556.
2. Balabanov S, Zimmermann U, Protzel C, Scharf C, Klebingat KJ, Walther R. Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by twodimensional gel electrophoresis. Eur J Biochem 2001; 268: 5977-5980.
3. Sandim V, Pereira DA, Ornellas AA, Alves G. Renal cell carcinoma and proteomics. Urol Int 2010; 84: 373-377.
4. Sarto C, Marocchi A, Sanchez JC, Giannone D, Frutiger S, Golaz O, et al. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997; 18: 599-604.
5. Craven RA, Stanley AJ, Hanrahan S, Dods J, Unwin R, Totty N, et al. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006; 6: 2853-2864.
6. Hwa JS, Kim HJ, Goo BM, Park HJ, Kim CW, Chung KH, et al. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. Proteomics 2006; 6: 1077-1084.
7. Hwa JS, Park HJ, Jung JH, Kam SC, Park HC, Kim CW, et al. Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J Korean Med Sci 2005; 20: 450-455.
8. Mueller-Lisse UG, Mueller-Lisse UL, Meindl T, Coppenrath E, Degenhart C, Graser A, et al. Staging of renal cell carcinoma. Eur Radiol 2007; 17: 2268-2277.
9. Sakaki M, Fukumori T, Fukawa T, Elsamman E, Shiirevnyamba A, Nakatsuji H, et al. Clinical significance of Galectin-3 in clear cell renal cell carcinoma. J Med Invest 2010; 57: 152-157.
10. Orsal AS, Ozsan M, Dolapci I, Tekeli A, Beksac M. Comparison of hybrid capture and reverse transcriptase polymerase chain reaction methods in terms of diagnosing human cytomegalovirus infection in patients following hematopoietic stem cell transplantation. Saudi Med J 2006; 27: 967-974.
11. Huang J, Wu K, Zhang J, Si W, Zhu Y, Wu J. Putative tumor suppressor YueF affects the functions of hepatitis B virus X protein in hepatoma cell apoptosis and p53 expression. Biotechnol Lett 2008; 30: 235-242.
12. Amato RJ. Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens. Ann Oncol 2005; 16: 7-15.
13. Sun CY, Zang YC, San YX, Sun W, Zhang L. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers. Saudi Med J 2010; 31: 525-532.
14. Okamura N, Masuda T, Gotoh A, Shirakawa T, Terao S, Kaneko N, et al. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics 2008; 8: 3194-3203.
15. Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, et al. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer 2006; 5: 64.
16. Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, et al. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003; 3: 1620-1632.
17. Yang J, Li A, Yang Y, Li X. Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis. Cancer Biol Ther 2011; 11: 535-546.
18. Humm A, Fritsche E, Steinbacher S, Huber R. Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. EMBO J 1997; 16: 3373-3385.
19. Watanabe Y, Van Pilsum JF, Yokoi I, Mori A. Synthesis of neuroactive guanidino compounds by rat kidney L-arginine: glycine amidinotransferase. Life Sci 1994; 55: 351-358.
20. Forestier M, Bänninger R, Reichen J, Solioz M. Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis. Biochim Biophys Acta 2003; 1638: 29-34.
21. Cheng P, Gong J, Wang T, Jie C, Liu GS, Zhang R. Gene expression in Barrett's esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats. World J Gastroenterol 2005; 11: 3277-3280.
22. McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int 2001; 59: 2267-2272.
23. Avila MA, Berasain C, Torres L, Martín-Duce A, Corrales FJ, Yang H, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000; 33: 907-914.
24. Park EI, Garrow TA. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem 1999; 274: 7816-7824.
25. Ghoshal K, Bai S. DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc) 2007; 43: 395-422.
26. Nabilsi NH, Broaddus RR, Loose DS. DNA methylation inhibits p53-mediated survivin repression. Oncogene 2009; 28: 2046-2050.
27. Kostka G, Urbanek-Olejnik K, Wiadrowska B. Di-butyl phthalate-induced hypomethylation of the c-myc gene in rat liver. Toxicol Ind Health 2010; 26: 407-416.
28. Yamazaki T, Nakano H, Hayakari M, Tanaka M, Mayama J, Tsuchida S. Differentiation induction of human keratinocytes by phosphatidylethanolamine-binding protein. J Biol Chem 2004; 279: 32191-32195.
29. Hengst U, Albrecht H, Hess D, Monard D. The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem 2001; 276: 535-540.
30. Wirth PJ, Hoang TN, Benjamin T. Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. Electrophoresis 1995;16: 1946-1960.
31. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006; 66: 248-256.
32. Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K, Bonavida B. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 2004; 91: 169-200.